| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.098 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |